Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Melar Acquisition I | MACI | Nov 27, 2024 | 10.06 | +0.11 |
Melco Resorts & Entertainment ADR | MLCO | Nov 27, 2024 | 6.20 | +3.68 |
MercadoLibre | MELI | Nov 27, 2024 | 2 044.76 | -3.09 |
Mercantile Bank | MBWM | Nov 27, 2024 | 50.53 | +0.86 |
Mercer International | MERC | Nov 27, 2024 | 6.21 | +1.14 |
Merchants Bancorp | MBIN | Nov 27, 2024 | 41.33 | -0.84 |
Merchants Bancorp B | MBINO | Nov 27, 2024 | 25.43 | +0.08 |
Merchants Bancorp C Pref | MBINN | Nov 27, 2024 | 22.82 | +0.95 |
Merchants Bancorp Pref D | MBINM | Nov 27, 2024 | 26.05 | -0.11 |
Merck & Co | MRK | Nov 27, 2024 | 103.12 | +1.48 |
Mercurity Fintech | MFH | Nov 27, 2024 | 6.10 | -16.32 |
Mercury General | MCY | Nov 27, 2024 | 78.85 | +0.60 |
Mercury Systems | MRCY | Nov 27, 2024 | 41.05 | -1.11 |
Mereo BioPharma ADR | MREO | Nov 27, 2024 | 3.56 | +4.71 |
Meridian | MRBK | Nov 27, 2024 | 16.73 | +0.48 |
MeridianLink | MLNK | Nov 27, 2024 | 22.92 | -1.16 |
Merit Medical Systems | MMSI | Nov 27, 2024 | 103.66 | -0.33 |
Meritage Homes | MTH | Nov 27, 2024 | 189.30 | -1.21 |
Merrill Lynch & Co. | IPB | Nov 27, 2024 | 25.88 | +0.66 |
Mersana Therapeutics | MRSN | Nov 27, 2024 | 2.19 | +0.92 |
Merus N.V | MRUS | Nov 27, 2024 | 44.97 | -1.96 |
Mesa Air Group | MESA | Nov 27, 2024 | 1.12 | +9.80 |
Mesa Laboratories | MLAB | Nov 27, 2024 | 118.35 | +1.63 |
Mesa Royalty Trust | MTR | Nov 27, 2024 | 7.17 | +0.73 |
Mesabi Royalty Trust | MSB | Nov 27, 2024 | 27.53 | +2.08 |
Mesoblast ADR | MESO | Nov 27, 2024 | 11.58 | +4.80 |
Meta Materials | MMAT | Nov 27, 2024 | 0.64 | 0.00 |
Meta Platforms A | META | Nov 27, 2024 | 569.20 | -0.76 |
Metagenomi | MGX | Nov 27, 2024 | 2.02 | +0.50 |
Metal Sky Star Acquisition | MSSA | Nov 27, 2024 | 12.00 | +2.83 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.